Table 1 Characteristics of the subjects at baseline examination
Variable | All subjects N = 80 |
|---|---|
Age, years, mean (SD) | 40.8 (12.7) |
Sex, male, n (%) | 24 (30.0%) |
Weight, kg, mean (SD) | 128.7 (18.3) |
Body-mass index, kg/m2, mean (SD) | 44.2 (3.9) |
Waist circumference, cm, mean (SD) | 134.1 (10.1) |
Cardiovascular risk factors, n (%) | |
 Preexisting cardiovascular disease | 1 (1.3%) |
 Hypertension | 37 (46.3%) |
 Type 2 diabetes mellitus | 25 (31.3%) |
 Prediabetes (IGT or IFG) | 14 (17.5%) |
 Current cigarette use | 33 (41.3%) |
 Hyperlipidemia | 20 (25.0%) |
Current therapy, n (%) | |
 Statins | 18 (22.5%) |
 Oral glucose lowering agents | 18 (22.5%) |
 Insulin | 5 (6.3%) |
 Blood pressure lowering agents | 37 (46.3%) |
 Angiotensin converting enzyme-inhibitors | 32 (40.0%) |
 Beta-blockers | 19 (23.8%) |